Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	11,026	11,047	11,725	6,784	6,230	4,494
Market Cap Growth	-5.78%	-5.78%	72.84%	8.89%	38.64%	67.94%
Enterprise Value	9,065	9,087	10,027	5,679	5,224	3,624
Last Close Price	549.80	551.50	584.68	337.47	307.44	221.71
PE Ratio	13.39	13.42	12.57	9.31	8.98	7.22
PS Ratio	1.71	1.71	2.02	1.33	1.32	1.06
PB Ratio	1.64	1.65	1.98	1.35	1.44	1.23
P/TBV Ratio	1.64	1.65	1.98	1.35	1.44	1.23
P/FCF Ratio	14.90	14.93	49.39	27.13	20.36	7.43
P/OCF Ratio	11.85	11.88	18.55	17.28	8.18	6.49
EV/Sales Ratio	1.40	1.41	1.73	1.11	1.11	0.85
EV/EBITDA Ratio	7.31	7.33	10.02	6.34	5.46	4.16
EV/EBIT Ratio	8.16	8.18	11.19	7.05	5.96	4.54
EV/FCF Ratio	12.25	12.28	42.23	22.71	17.07	5.99
Debt / Equity Ratio	-	-	0.00	0.00	0.01	0.00
Debt / EBITDA Ratio	-	-	0.01	0.02	0.02	0.01
Debt / FCF Ratio	-	-	0.05	0.08	0.07	0.01
Asset Turnover	0.86	0.86	0.90	0.91	0.96	1.01
Inventory Turnover	3.74	3.74	3.84	3.44	3.72	4.29
Quick Ratio	3.42	3.42	3.32	3.39	2.56	2.74
Current Ratio	4.71	4.71	4.84	5.09	3.90	4.07
Return on Equity (ROE)	13.02%	13.02%	17.04%	15.59%	17.36%	18.31%
Return on Assets (ROA)	9.27%	9.27%	8.70%	8.97%	11.11%	11.85%
Return on Capital (ROIC)	10.97%	10.97%	10.20%	10.72%	13.67%	14.55%
Return on Capital Employed (ROCE)	16.10%	16.10%	14.70%	15.60%	19.80%	21.20%
Earnings Yield	7.47%	7.45%	7.96%	10.75%	11.13%	13.85%
FCF Yield	6.71%	6.70%	2.02%	3.69%	4.91%	13.47%
Dividend Yield	0.30%	-	0.31%	0.44%	0.49%	0.68%
Payout Ratio	4.38%	4.38%	3.22%	4.12%	4.33%	-
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-	-0.15%
Total Shareholder Return	0.29%	-0.01%	0.31%	0.44%	0.49%	0.53%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.